New drug could cut IV nutrition needs for short bowel patients
NCT ID NCT06973304
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests a drug called teduglutide in 13 Chinese adults with short bowel syndrome who rely on IV nutrition. Participants get a daily injection for 24 weeks to see if it reduces their need for IV support. The study also checks safety and how the body processes the drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
teduglutide (a drug that helps the intestines absorb more nutrients)
What this could lead to
If it works, this could help people with short bowel syndrome reduce their dependence on intravenous nutrition, improving daily life.
What could go wrong
This is a small, early-phase trial with only 13 participants, so results may not apply to everyone. The drug may not work as hoped, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Jinling Hospital, Medical School of Nanjing University
RECRUITINGNanjing, Jiangsu, 210016, China
Contact Email: •••••@•••••
Contact
-
Beijing Tsinghua Changgung Hospital
RECRUITINGChangping, Beijing Municipality, 102218, China
Contact
Contact Email: •••••@•••••
-
Peking Union Medical College Hospital
RECRUITINGDongcheng, Beijing Municipality, 100730, China
Contact Email: •••••@•••••
Contact
-
Zhongshan Hospital, Xiamen University
COMPLETEDSiming, Xiamen, 361004, China